Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

Thanks and I see that I was remiss in not making clear a few more things about the triumvirate that are in contrast to Elite. First, none of the three (FLXN, PBYI & PTLA) have their own manufacturing capabilities, all will be using contract manufacturing with whom the costs are as yet built into their financials. Second, all have cash but indicated that manufacturing and full commercialization are costs that will likely lead to dilution. Finally, PBYI has had a couple of setbacks with the FDA and their current p/s is down about 82% from the high of two years ago. Again, as mentioned...

If PUMA had the same outstanding share count as Elite, with no revenues, it would be priced at $1.24 p/s.
Flexion, with the same outstanding share count as Elite and no revenues, would be priced at 87 cents p/s.
Portola, with the same outstanding share count as Elite and no revenues, would be priced at $2.11 p/s.